Martin Roper
On April 14, 2025, Gerardo I. Lopez and Martin Roper were elected as Group B members of the Board of Directors (the “Board”) of MGP Ingredients, Inc.
Highest-materiality recent filing
MGP Ingredients Q1 net loss $134.8M on $179.5M non-cash impairments; adj. EPS $0.15
Revenue fell 13% to $106.4M; net loss of $134.8M ($6.30 basic loss) vs year-ago loss of $3.0M.
Temporary idling of Limestone Branch (Lebanon, KY) and Lux Row (Bardstown, KY) effective May 1, 2026.
MGP Ingredients Q4 net loss $134.6M includes $152.6M impairment; FY sales -24%
Q4 net loss of $134.6M, includes $152.6M non-cash goodwill/intangibles impairment (Branded Spirits).
MGP Ingredients Q3 sales -19% to $130.9M, net income -35%; raises FY adjusted EBITDA, EPS outlook
Q3 consolidated sales $130.9M (-19% YoY); gross profit $49.4M (-25%); net income $15.4M (-35%).
MGP Ingredients Q2 sales -24% to $145.5M, net income -55%; new CEO Julie Francis appointed
Sales down 24% to $145.5M; gross profit -30% to $58.4M; margin 40.1% (-350bps).
MGP Ingredients appoints Julie Francis as CEO; reaffirms FY2025 guidance
Julie Francis named President and CEO effective July 21, 2025; previously COO at Schwan's Company.
MGP Ingredients Q1 net loss $3.1M; sales down 29%, reaffirms 2025 outlook
Net loss of $3.1M vs $19.9M income in Q1 2024; basic EPS loss $0.14.
MGP Ingredients Q4 net loss $42M on goodwill impairment; 2025 guidance well below 2024
Q4 net loss $42M ($1.91 basic EPS loss) includes $73.8M non-cash goodwill impairment; adjusted EPS $1.57.
MGP Ingredients names CFO Brandon Gall interim CEO; Donn Lux becomes chairman
David Bratcher steps down as CEO and resigns from board effective Dec 31, 2024; gets transition and severance benefits.
Consolidated sales $161.5M, down 24% YoY; excluding Atchison distillery, down 14%.
MGP Ingredients preliminary Q3 sales down 24%, cuts full-year guidance significantly
Preliminary Q3 sales $161.5M, -24% YoY; net income $23.9M (+82%) but adjusted EPS down 5% to $1.29.
MGP Ingredients Q2 2024: adjusted EPS up 15% to $1.71; reaffirms FY guidance
Sales fell 9% to $190.8M due to Atchison closure; ex-distillery, sales up 7%.
MGP Ingredients Q1 net income down 34% to $20.6M; reaffirms FY2024 guidance
Sales decreased 15% to $170.6M; gross profit down 10% to $62.8M.
MGP Ingredients Chief Legal Officer Curtis Landherr resigns; transition period through May 31, 2024
Curtis Landherr, Chief Legal Officer, VP, and Corporate Secretary, resigns effective May 31, 2024; officer roles end April 30.
MGP Ingredients Q4 2023 sales up 13%; adj. diluted EPS $1.64 vs $1.01; FY2024 guide
Q4 sales $214.9M (+13%), gross profit $85.1M (+35%), adjusted diluted EPS $1.64 vs $1.01 YoY.
MGP Ingredients Q3 sales up 5% to $211.6M; CEO Colo to retire, Bratcher named successor
Q3 sales $211.6M (+5% YoY); gross profit $73.4M (+24%); adjusted diluted EPS $1.34 vs $1.06 YoY.
MGP Ingredients reports record Q2 sales $209M, net income up 26%; raises FY2023 guidance
Q2 sales $209.0M (+7% YoY); net income $32.0M (+26%); diluted EPS $1.44 vs $1.15.
MGP Ingredients to close Atchison distillery; FY2023 charges $23-31M
Closure of grain neutral spirits and industrial alcohol distillery expected by January 2024.
MGP Ingredients Q1 sales up 3% to $201M; net income down 17% to $31M; reaffirms FY guidance
Diluted EPS fell to $1.39 from $1.69 YoY; adjusted EBITDA down 15% to $47.1M.
MGP Ingredients reports record FY2022 sales up 25% to $782.4M; net income up 20%
Q4 sales $191.0M (+15% YoY); adjusted diluted EPS $1.01 vs $0.88.
MGP Ingredients Q3 sales up 14% to $201.2M; raises FY2022 guidance
Q3 sales $201.2M (+14% YoY); net income $23.6M vs $23.7M; diluted EPS $1.06 vs $1.08.
MGP Ingredients Q2 2022 sales up 11% to $195M; net income up 26%; raises FY guidance
Sales $195.0M (+11% YoY); operating income $35.3M (+28%); net income $25.4M (+26%).
Q1 sales up 80.2% to $195.2M; EPS $1.69 vs $0.90
Sales $195.2M (+80.2% YoY); operating income $50.1M (+144.3%).
MGP Ingredients reports record FY2021 sales of $626.7M (+58.5%), raises 2022 guidance
Full-year diluted EPS rose to $4.34 from $2.37; adjusted EPS $4.24 vs $2.51.
MGP Ingredients closes $201.2M 1.875% convertible note offering due 2041
$201.2M notes (incl. full $26.25M greenshoe) with 1.875% coupon, due Nov 2041, sold in 144A placement.
MGP Ingredients prices $175M convertible notes offering to reduce revolving credit facility debt
Priced $175 million aggregate principal amount of 1.875% convertible senior notes due 2041 in a private offering.
Pro forma combined sales $503.7M, net income $55.6M, diluted EPS $2.53 for YTD Sept 30, 2021.
MGP Ingredients Q3 sales up 71.5% to $176.6M, EPS $1.08, raises full-year guidance
Consolidated sales $176.6M (+71.5%), gross profit $57.1M (+146.5%), operating income $32.9M (+140.9%).
On April 14, 2025, Gerardo I. Lopez and Martin Roper were elected as Group B members of the Board of Directors (the “Board”) of MGP Ingredients, Inc.
On April 14, 2025, Gerardo I. Lopez and Martin Roper were elected as Group B members of the Board of Directors (the “Board”) of MGP Ingredients, Inc.
In addition, Preet H. Michelson resigned as a Group B member of the Board, effective April 14, 2025.
On April 22, 2024, Curtis C. Landherr, the Chief Legal Officer, Vice President, and Corporate Secretary and a named executive officer of MGP Ingredients, Inc. (the “Company”) notified the Company that he is resigning from the Company, effective May 31, 2024.
On January 12, 2024, Stephen J. Glaser, Vice President of Production and Engineering and a named executive officer of MGP Ingredients, Inc. (the “Company”), notified the Company that he will be retiring from his position effective July 31, 2024.
David S. Bratcher was elected as a Group B member of the Board of Directors (the “Board”) of MGP Ingredients, Inc. (the “Company”), effective January 1, 2024
Mr. Bratcher was also appointed to serve as the Company’s Chief Executive Officer and President, effective January 1, 2024
The Company will seek to have Mr. Bratcher elected as a Class B director of the Company effective January 1, 2024.
On August 5, 2022, MGP Ingredients, Inc. (the “Company”) entered into a letter agreement with David Dykstra, the Company’s Vice President of Alcohol Sales, in connection with his planned retirement from the Company on December 31, 2022.
As a result, David Dykstra, Vice President of Alcohol Sales, and Stephen Glaser, Vice President of Production and Engineering, two of the named executive officers listed in last year’s proxy statement have ceased to be Section 16 reporting officers.
As a result, David Dykstra, Vice President of Alcohol Sales, and Stephen Glaser, Vice President of Production and Engineering, two of the named executive officers listed in last year’s proxy statement have ceased to be Section 16 reporting officers.
On July 13, 2021, MGP Ingredients, Inc. (the “Company”) announced the appointment of David S. Bratcher as Chief Operating Officer, effective July 6, 2021.
Max materiality 0.90 · Median 0.60 · Most common event earnings